Mark J. Rubash Sells 3,000 Shares of Intuitive Surgical, Inc. (ISRG) Stock
Intuitive Surgical, Inc. (NASDAQ:ISRG) Director Mark J. Rubash sold 3,000 shares of the business’s stock in a transaction dated Thursday, June 8th. The stock was sold at an average price of $931.51, for a total transaction of $2,794,530.00. Following the sale, the director now directly owns 4,151 shares of the company’s stock, valued at $3,866,698.01. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.
Shares of Intuitive Surgical, Inc. (ISRG) traded up 1.77% during midday trading on Friday, reaching $914.84. 574,934 shares of the company’s stock were exchanged. Intuitive Surgical, Inc. has a 12-month low of $610.71 and a 12-month high of $937.15. The stock has a market cap of $33.70 billion, a PE ratio of 46.12 and a beta of 0.41. The stock’s 50 day moving average is $883.02 and its 200-day moving average is $751.79.
Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Tuesday, April 18th. The medical equipment provider reported $5.09 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.97 by $1.12. The firm had revenue of $674.20 million for the quarter, compared to analyst estimates of $664.72 million. Intuitive Surgical had a net margin of 27.99% and a return on equity of 15.41%. Intuitive Surgical’s revenue was up 13.4% on a year-over-year basis. During the same period in the previous year, the firm earned $4.42 EPS. On average, equities analysts expect that Intuitive Surgical, Inc. will post $23.64 EPS for the current year.
A number of equities research analysts have issued reports on the stock. BTIG Research reaffirmed a “hold” rating on shares of Intuitive Surgical in a research report on Thursday. BidaskClub downgraded shares of Intuitive Surgical from a “strong-buy” rating to a “buy” rating in a research report on Tuesday. Zacks Investment Research raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating and set a $1,035.00 target price for the company in a research report on Thursday, June 8th. Bank of America Corporation reissued a “buy” rating and set a $1,000.00 target price on shares of Intuitive Surgical in a research report on Thursday, June 1st. Finally, Canaccord Genuity cut shares of Intuitive Surgical from a “buy” rating to a “hold” rating and set a $870.00 price target on the stock. in a research note on Tuesday, May 30th. They noted that the move was a valuation call. One analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have issued a buy rating to the company. The company currently has a consensus rating of “Buy” and a consensus price target of $856.69.
A number of hedge funds have recently modified their holdings of the stock. BlackRock Inc. raised its stake in shares of Intuitive Surgical by 2,770.9% in the first quarter. BlackRock Inc. now owns 2,846,621 shares of the medical equipment provider’s stock valued at $2,181,851,000 after buying an additional 2,747,465 shares during the period. Vanguard Group Inc. raised its stake in shares of Intuitive Surgical by 1.2% in the first quarter. Vanguard Group Inc. now owns 2,503,817 shares of the medical equipment provider’s stock valued at $1,919,101,000 after buying an additional 30,306 shares during the period. FMR LLC raised its stake in shares of Intuitive Surgical by 3.4% in the first quarter. FMR LLC now owns 2,277,567 shares of the medical equipment provider’s stock valued at $1,745,686,000 after buying an additional 75,894 shares during the period. State Street Corp raised its stake in shares of Intuitive Surgical by 7.2% in the fourth quarter. State Street Corp now owns 1,635,347 shares of the medical equipment provider’s stock valued at $1,037,088,000 after buying an additional 110,302 shares during the period. Finally, Edgewood Management LLC increased its position in Intuitive Surgical by 38.8% in the first quarter. Edgewood Management LLC now owns 919,617 shares of the medical equipment provider’s stock valued at $704,859,000 after buying an additional 257,165 shares in the last quarter. Hedge funds and other institutional investors own 97.58% of the company’s stock.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
Receive News & Stock Ratings for Intuitive Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical Inc. and related stocks with our FREE daily email newsletter.